[{{{type}}}] {{{reason}}}
{{/data.error.root_cause}}{{{_source.displayDate}}}
{{/_source.showDate}}{{{_source.description}}}
{{#_source.additionalInfo}}{{#_source.additionalFields}} {{#title}} {{{label}}}: {{{title}}} {{/title}} {{/_source.additionalFields}}
{{/_source.additionalInfo}}: Higher-sensitivity physical methods used for precise leak detection. Impact on Global Standards
: While it emphasizes packaging for sterile products , the principles are applicable to any nonporous barrier system protecting a pharmaceutical product.
: Often considered the gold standard for validating a sterile barrier. pda technical report 27 pdf
: A traditional physical method often correlated to microbial results.
: The report introduced modernized terms, such as "product package" (instead of container/closure system) and "package seal" to encompass diverse sealing technologies. Lifecycle Integrity Assessment : Higher-sensitivity physical methods used for precise leak
: Stability studies must include integrity tests to confirm that the package maintains its barrier properties under typical storage conditions until the product's expiration. Methodologies and Validation
: Regular monitoring during production, such as visual inspections and automated leak detection, helps identify defects early. : A traditional physical method often correlated to
, titled "Pharmaceutical Package Integrity," is a foundational guidance document published by the Parenteral Drug Association (PDA) that establishes best practices for ensuring the barrier qualities of pharmaceutical packaging. Originally released in 1998 to supersede Technical Information Bulletin No. 4, it remains a critical reference for manufacturers developing strategies to protect sterile products from environmental contamination and maintain product stability throughout their lifecycle. Key Objectives of TR 27